Role of circulating tumor DNA in the management of early-stage lung cancer
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Role of circulating tumor DNA in the management of early-stage lung cancer
Authors
Keywords
-
Journal
Thoracic Cancer
Volume 9, Issue 5, Pages 509-515
Publisher
Wiley
Online
2018-03-12
DOI
10.1111/1759-7714.12622
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Lung cancer's real adjuvant EGFR targeted therapy questions
- (2018) Terry L Ng et al. LANCET ONCOLOGY
- Gefitinib versus vinorelbine plus cisplatin as adjuvant treatment for stage II–IIIA (N1–N2) EGFR -mutant NSCLC (ADJUVANT/CTONG1104): a randomised, open-label, phase 3 study
- (2018) Wen-Zhao Zhong et al. LANCET ONCOLOGY
- Detection and localization of surgically resectable cancers with a multi-analyte blood test
- (2018) Joshua D. Cohen et al. SCIENCE
- Comparison of plasma to tissue DNA mutations in surgical patients with non–small cell lung cancer
- (2017) Kezhong Chen et al. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY
- Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution
- (2017) Christopher Abbosh et al. NATURE
- Circulating tumour DNA methylation markers for diagnosis and prognosis of hepatocellular carcinoma
- (2017) Rui-hua Xu et al. NATURE MATERIALS
- Integrating liquid biopsies into the management of cancer
- (2017) Giulia Siravegna et al. Nature Reviews Clinical Oncology
- Tracking the Evolution of Non–Small-Cell Lung Cancer
- (2017) Mariam Jamal-Hanjani et al. NEW ENGLAND JOURNAL OF MEDICINE
- Combined circulating tumor DNA and protein biomarker-based liquid biopsy for the earlier detection of pancreatic cancers
- (2017) Joshua D. Cohen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Early Detection of Molecular Residual Disease in Localized Lung Cancer by Circulating Tumor DNA Profiling
- (2017) Aadel A. Chaudhuri et al. Cancer Discovery
- FDA Approval of Gefitinib for the Treatment of Patients with Metastatic EGFR Mutation-Positive Non-Small Cell Lung Cancer
- (2016) D. Kazandjian et al. CLINICAL CANCER RESEARCH
- Identification of Circulating Tumor DNA for the Early Detection of Small-cell Lung Cancer
- (2016) Lynnette Fernandez-Cuesta et al. EBioMedicine
- Diagnostic Accuracy of Noninvasive Genotyping of EGFR in Lung Cancer Patients by Deep Sequencing of Plasma Cell-Free DNA
- (2015) J. Uchida et al. CLINICAL CHEMISTRY
- Adjuvant Erlotinib Versus Placebo in Patients With Stage IB-IIIA Non–Small-Cell Lung Cancer (RADIANT): A Randomized, Double-Blind, Phase III Trial
- (2015) Karen Kelly et al. JOURNAL OF CLINICAL ONCOLOGY
- Evaluation of RECIST in chemotherapy-treated lung cancer: the Pharmacogenoscan Study
- (2015) Anne-Claire Toffart et al. BMC CANCER
- Circulating tumor cells and circulating tumor DNA for precision medicine: dream or reality?
- (2014) M. Ignatiadis et al. ANNALS OF ONCOLOGY
- High Resolution Melting Analysis for Epidermal Growth Factor Receptor Mutations in Formalin-fixed Paraffin-embedded Tissue and Plasma Free DNA from Non-small Cell Lung Cancer Patients
- (2014) Chang-Wen Jing et al. Asian Pacific Journal of Cancer Prevention
- Liquid Biopsies: Genotyping Circulating Tumor DNA
- (2014) Luis A. Diaz et al. JOURNAL OF CLINICAL ONCOLOGY
- An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage
- (2014) Aaron M Newman et al. NATURE MEDICINE
- What is next generation sequencing?
- (2013) Sam Behjati et al. Archives of Disease in Childhood-Education and Practice Edition
- Circulating cell free DNA: Preanalytical considerations
- (2013) Safia El Messaoudi et al. CLINICA CHIMICA ACTA
- Quantitative Cell-Free DNA, KRAS, and BRAF Mutations in Plasma from Patients with Metastatic Colorectal Cancer during Treatment with Cetuximab and Irinotecan
- (2012) K.-L. G. Spindler et al. CLINICAL CANCER RESEARCH
- Tumor Response and Toxicity of Neoadjuvant Erlotinib in Patients With Early-Stage Non–Small-Cell Lung Cancer
- (2012) Eva E. Schaake et al. JOURNAL OF CLINICAL ONCOLOGY
- Application of a Highly Sensitive Detection System for Epidermal Growth Factor Receptor Mutations in Plasma DNA
- (2012) Tomomi Nakamura et al. Journal of Thoracic Oncology
- Direct serum and tissue assay for EGFR mutation in non-small cell lung cancer by high-resolution melting analysis
- (2012) CHENGJIN HU et al. ONCOLOGY REPORTS
- Comparison of Epidermal Growth Factor Receptor Mutation Statuses in Tissue and Plasma in Stage IIV Non-Small Cell Lung Cancer Patients
- (2012) Xiao Zhao et al. RESPIRATION
- Base-calling for next-generation sequencing platforms
- (2011) C. Ledergerber et al. BRIEFINGS IN BIOINFORMATICS
- Phase II Study of Preoperative Gefitinib in Clinical Stage I Non–Small-Cell Lung Cancer
- (2009) Humberto Lara-Guerra et al. JOURNAL OF CLINICAL ONCOLOGY
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
- (2008) E.A. Eisenhauer et al. EUROPEAN JOURNAL OF CANCER
- Circulating mutant DNA to assess tumor dynamics
- (2008) Frank Diehl et al. NATURE MEDICINE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now